DeepTek

DeepTek.ai is a pioneering company in the medical imaging sector, leveraging advanced artificial intelligence (AI) to enhance the quality and accessibility of radiology services. The company primarily serves hospitals, imaging centers, and government health programs, particularly in India and the Asia-Pacific (APAC) region. DeepTek.ai operates in the healthcare technology market, focusing on AI-driven solutions that optimize radiology workflows and improve diagnostic accuracy. Its flagship product, Augmento, is a US FDA-cleared platform that integrates seamlessly into existing radiology systems, automating tasks and enabling faster, more accurate diagnoses. The business model revolves around providing AI-powered software solutions on a subscription basis, generating revenue through licensing fees and service contracts. By making radiology more efficient and accessible, DeepTek.ai creates significant value for patients, healthcare providers, and public health initiatives. The company is currently engaged in large-scale public health screening programs for diseases like Tuberculosis and COVID-19, demonstrating its commitment to social impact and healthcare innovation.

Keywords: AI, radiology, medical imaging, healthcare technology, diagnostics, workflow optimization, public health, subscription model, FDA-cleared, automation.